688520.SH
神州细胞
SSE · Healthcare · Biotechnology · CN
CNY 36.39
−3.96%Margins
Gross margin
91.6%
EBITDA margin
-19.6%
EBIT margin
-45.3%
Net margin
-59.0%
FCF margin
-37.8%
-94.9%
Return on equity
-17.7%
Return on assets
-17.9%
Return on invested capital
0.33x
Asset turnover
-CNY 261.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026